
Liver Cancer in Mexico: Why Are Men Diagnosed Later? - Medscape
Mar 4, 2025 · New research reveals distinct epidemiological trends in liver cancer across Mexico, with gender and regional variations shaping disease presentation.
Rite of Passage or Road to Early Liver Damage? - Medscape
Mar 20, 2025 · SLD is a silent disease, and patients are most often detected due to abnormal liver chemistries or a finding of steatosis in the liver from an ultrasound performed for another indication.
Understanding Obesity’s Role in GI and Liver Complications
Jan 14, 2025 · Understanding the association between excess body weight and gastrointestinal liver complications is important because we do have data that suggest that weight loss can improve these outcomes.
Laparoscopic Liver Resection Can Speed Patient Recovery Time
Mar 13, 2025 · Laparoscopic liver resection in posterosuperior segments was linked to a shorter functional recovery time and postoperative hospital stay than open surgery in a recent clinical trial.
Bariatric Surgery Lowers Risk for Liver Complications in MASH
Feb 26, 2025 · Bariatric surgery reduces the progression to decompensated cirrhosis and the risk for major adverse liver outcomes, such as cancer and transplantation.
The Most Common Chronic Liver Disease in the World - Medscape
Nov 7, 2024 · He isn’t using the test to catch someone in a lie about their alcohol use. He tells patients that he orders this test for all patients with liver inflammation, because alcohol is a common cause.
Geriatric Assessment: Abdominal and Rectal Examination
Aug 2, 2012 · A liver span less than 9 cm suggests cirrhosis. Be aware that pleural effusion and right lower lobe pneumonia can give a false sense of the upper liver margin.
GLP-1 RAs Cut Cardiovascular Risk in Metabolic Liver Disease
Mar 6, 2025 · A large population-based cohort study reports that using GLP-1 RAs significantly reduces the risk for cardiovascular events and mortality in patients with MASLD.
The Growing Burden of Fatty Liver Disease: What’s Next?
Feb 26, 2025 · The global rise in obesity and type 2 diabetes is fueling an epidemic of MASLD and MASH, now recognized as the leading cause of liver-related complications.
In HCV, Starting Treatment Trumps Staging for Liver Fibrosis
Jan 2, 2025 · Biomarker staging of liver fibrosis in hepatitis C was cost effective, but so was initiating treatment without testing.